Please use this identifier to cite or link to this item: http://hdl.handle.net/2445/128774
Full metadata record
DC FieldValueLanguage
dc.contributor.authorPujol, Eugènia-
dc.contributor.authorBlanco-Cabra, Núria-
dc.contributor.authorJulián, Esther-
dc.contributor.authorLeiva Martínez, Rosana-
dc.contributor.authorTorrents Serra, Eduard-
dc.contributor.authorVázquez Cruz, Santiago-
dc.date.accessioned2019-02-25T11:46:03Z-
dc.date.available2019-02-25T11:46:03Z-
dc.date.issued2018-11-02-
dc.identifier.issn1420-3049-
dc.identifier.urihttp://hdl.handle.net/2445/128774-
dc.description.abstractConcerns have been raised about the long-term accumulating effects of triclocarban, a polychlorinated diarylurea widely used as an antibacterial soap additive, in the environment and in human beings. Indeed, the Food and Drug Administration has recently banned it from personal care products. Herein, we report the synthesis, antibacterial activity and cytotoxicity of novel N,N'-diarylureas as triclocarban analogs, designed by reducing one or more chlorine atoms of the former and/or replacing them by the novel pentafluorosulfanyl group, a new bioisostere of the trifluoromethyl group, with growing importance in drug discovery. Interestingly, some of these pentafluorosulfanyl-bearing ureas exhibited high potency, broad spectrum of antimicrobial activity against Gram-positive bacterial pathogens, and high selectivity index, while displaying a lower spontaneous mutation frequency than triclocarban. Some lines of evidence suggest a bactericidal mode of action for this family of compounds. Keywords: antibacterial; Gram-positive; N,N0-diarylureas; pentafluorosulfanyl; Staphylococcus aureus; triclocarban-
dc.format.mimetypeapplication/pdf-
dc.language.isoeng-
dc.publisherMDPI-
dc.relation.isformatofReproducció del document publicat a: https://doi.org/10.3390/molecules23112853-
dc.relation.ispartofMolecules, 2018, vol. 23, num. 11, p. 2853-
dc.relation.urihttps://doi.org/10.3390/molecules23112853-
dc.rightscc-by (c) Pujol, Eugènia et al., 2018-
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/es-
dc.sourceArticles publicats en revistes (Farmacologia, Toxicologia i Química Terapèutica)-
dc.subject.classificationMedicaments antibacterians-
dc.subject.classificationCitotoxicitat per mediació cel·lular-
dc.subject.classificationDisseny de medicaments-
dc.subject.classificationSíntesi orgànica-
dc.subject.classificationEstafilococs-
dc.subject.otherAntibacterial agents-
dc.subject.otherCell-mediated cytotoxicity-
dc.subject.otherDrug design-
dc.subject.otherOrganic synthesis-
dc.subject.otherStaphylococcus-
dc.titlePentafluorosulfanyl-containing Triclocarban Analogs with Potent Antimicrobial Activity-
dc.typeinfo:eu-repo/semantics/article-
dc.typeinfo:eu-repo/semantics/publishedVersion-
dc.identifier.idgrec682858-
dc.date.updated2019-02-25T11:46:03Z-
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess-
dc.identifier.pmid30400165-
Appears in Collections:Articles publicats en revistes (Institut de Biomedicina (IBUB))
Articles publicats en revistes (Farmacologia, Toxicologia i Química Terapèutica)

Files in This Item:
File Description SizeFormat 
682858.pdf1.9 MBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons